<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996135</url>
  </required_header>
  <id_info>
    <org_study_id>19-043</org_study_id>
    <nct_id>NCT03996135</nct_id>
  </id_info>
  <brief_title>Evaluation of Accuvein in Cirrhotics Patients</brief_title>
  <acronym>CIRRVVUS</acronym>
  <official_title>Study of the Effectiveness of a Venous Illumination System for Peripheral Venous Pathways in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the effectiveness of AccuVein AV400 to facilitate
      placement of peripheral intravenous catheters in cirrhotic adults by comparing the success
      rate of the first attempt to install a peripheral venous catheter with or without AccuVein
      AV400®.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Attempt Success Rate of Cannulation</measure>
    <time_frame>baseline</time_frame>
    <description>Firt attempt success of positional for each peripheral venous catheter and expressed as a percentage in cirrhotic patients during hospitalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of the score A-DIVA</measure>
    <time_frame>baseline and end of hospitalization (up to a month)</time_frame>
    <description>Scores A-DIVA between beginning and end of hospitalization between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost</measure>
    <time_frame>baseline</time_frame>
    <description>Cost of consumables used in euro between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life expectancy of the catheter</measure>
    <time_frame>baseline</time_frame>
    <description>Life expectancy of the catheter between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utilisation of a central venous catheter</measure>
    <time_frame>baseline</time_frame>
    <description>Use of a central venous catheter (y/n)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain's score</measure>
    <time_frame>baseline</time_frame>
    <description>visual analogic scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numbers of attempts</measure>
    <time_frame>baseline</time_frame>
    <description>Number of attempts between two groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Experimental : Cannulation with AccuVein AV400</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cirrhotic patients benefit from the support of a venous illumination device for each peripheral venous cannulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cirrhotic patients benefit from the standard technique of peripheral veinous catheter placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cannulation with AccuVein AV400</intervention_name>
    <description>Cannulation using AccuVein AV400 device</description>
    <arm_group_label>Experimental : Cannulation with AccuVein AV400</arm_group_label>
    <other_name>AccuVein AV400</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient older than 18 years old

          -  Patient presenting a liver cirrhosis

          -  Patient requiring the placement of a venous peripheral catheter

          -  Patient informed and giving free and informed consent

          -  Patient affiliated to a French social security scheme

        Exclusion Criteria:

          -  Patient under 18 years old

          -  Patient unable to give consent

          -  Patient under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe Moiteaux</last_name>
    <phone>0231064542</phone>
    <email>moiteaux-p@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nelly Orliac</last_name>
    <phone>0231063082</phone>
    <email>orliac-n@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Moiteaux</last_name>
      <phone>+33231063106</phone>
      <email>moiteaux-p@chu-caen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Clémence Tomadesso</last_name>
      <phone>+33231065386</phone>
      <email>tomadesso-c@chu-caen.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2019</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

